Latest Kansas Bioscience Authority Stories
OLATHE, Kan., Oct. 15, 2012 /PRNewswire/ -- The Kansas Bioscience Authority today announced its outcomes for fiscal 2012, which ended June 30, and cumulative outcomes since the KBA's inception. The following direct outcomes, all directly related to KBA investments, are reported annually based on information provided by KBA client companies and universities: Kansas Bioscience Authority Investments & Outcomes...
MANHATTAN, Kan., Aug. 7, 2012 /PRNewswire/ -- Heartland Plant Innovations (HPI) has been awarded $2.5 million in funding from the Kansas Bioscience Authority (KBA) for the fiscal year beginning July 1, 2012. HPI will utilize this funding to continue its mission of accelerating research, development, and commercialization of profitable innovations in the market performance of wheat and sorghum. As with other KBA awards, funding is tied to HPI's achievement of key milestones during...
OLATHE, Kan., Nov. 16, 2011 /PRNewswire/ -- The Kansas Bioscience Authority today announced its outcomes for fiscal year 2011, which ended June 30, and cumulative outcomes since the KBA's inception. The following direct outcomes, all related to KBA investments, are reported annually based on information provided by KBA client companies and universities: New, full-time jobs created by bioscience companies in Kansas;New, external research funding attracted to Kansas;Capital expenditures in...
Leading pharmaceutical and biotech companies outsource more than $1 billion in drug development research to area organizations CHICAGO, June 21, 2011 /PRNewswire-USNewswire/ -- According to a new study released today at the annual meeting of the Drug Information Association in Chicago, the greater Kansas City region is home to a significant cluster of contract research organizations (CROs) and contract service providers (CSPs), with more than $1 billion in annual revenue. Commissioned...
UNION CITY, Calif., May 11, 2011 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that it was awarded $650,000 from the Kansas Bioscience Authority to help set up the first laboratory testing facility for veterinarians nationwide in Olathe, Kansas. The authority's board of directors on May 9, 2011 approved the three-year grant during meetings in Wichita, Kansas. In January 2011, Abaxis formed a...
OLATHE, Kan. Oct. 9 /PRNewswire-USNewswire/ -- The Kansas Bioscience Authority has taken bold action to significantly increase the amount of venture capital available to innovative Kansas bioscience businesses -- and to lead the state's economic recovery -- approving a commitment to invest $50 million in eight private venture capital funds. The KBA investments will create a powerful magnet for private capital investment from around the country in Kansas bioscience companies. To qualify for...
$11 Million in New Projects Approved in Atlanta ATLANTA, May 19 /PRNewswire-USNewswire/ -- Meeting at the world's largest bioscience and biotechnology convention, the Kansas Bioscience Authority has approved more than $11 million in new investments as part of a $581 million initiative to help researchers and businesses thrive in the state. The funding decisions made at the Bio International Convention will create bioscience centers of innovation in biomaterials and plant biology, expand...
SAN DIEGO, June 18 /PRNewswire/ -- Kansas researchers and companies excel in the human health biosciences, and $3.7 million in new Kansas Bioscience Authority (KBA) investments in that sector will support cutting-edge innovations for the treatment of cancer, HIV, and osteoporosis, as well as in pharmaceutical development. "Kansas has tremendous human-health research capabilities and strong corporate clustering, and we're using those strengths to address critical national and international...
